RecallRadar

FDA Device recall Z-0106-2016

Syngo RT Oncologist, an optional accessory to the linear accelerator system and permits localization, contouring, segmentation, image revie…

On 2015-10-14 the FDA classified a Class II recall of Syngo RT Oncologist, an optional accessory to the linear accelerator system and permits localization, contouring, segmentation, image revie… by Siemens Medical Solutions Usa, citing this update is intended to provide a software update for the Syngo RT Oncologist, which is currently running SW version 4.2 or 4.3. The safety-related issues, which were described….

Read the official FDA Device notice

AgencyFDA Device
Recall numberZ-0106-2016
ClassificationClass II
Statusterminated
Initiated2015-08-11
Published2015-10-14
Last updated2026-09-13 11:53 UTC
CompanySiemens Medical Solutions Usa
DistributionMA, MO, OH, PA, UT, WI

Product

Syngo RT Oncologist, an optional accessory to the linear accelerator system and permits localization, contouring, segmentation, image review, and review and approval of treatment plan parameters. In addition, it includes tools and administrative functions to aid in the diagnosis, staging, and prescription of radiation therapy.

Reason

This update is intended to provide a software update for the Syngo RT Oncologist, which is currently running SW version 4.2 or 4.3. The safety-related issues, which were described in the Customer Safety Notice distributed as UFSN-RTT/RTO 4.3 Adaptive Targeting [Auto-registration]. The update contains several important safety and performance fixes.

Identifiers

code_infoModel Number of device- 10568604, serial numbers: 10206 10337 10338 10100 10289 10197 10131 10179 10184 10158 10235 10236 10080 10296

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:53 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0106-2016%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.